Dr Reddy's Laboratories share price falls 0.74% to ₹1,342 on November 2

Key Takeaways

• Dr Reddy's Laboratories closed at ₹1,342, down 0.74%, after trading between ₹1,337 and ₹1,365.
• Despite the daily decline, the close remained more than ₹100 above each of its 50-day, 100-day and 200-day DMAs.
• Returns were positive across all four displayed periods, led by a 16.89% three-month gain and 12.06% one-year return.

Dr Reddy's Laboratories share price closed November 2 at ₹1,342, down 0.74% from the previous close of ₹1,352. The stock opened at ₹1,352, climbed to ₹1,365 and later dropped to ₹1,337. It finished ₹5 above the session low and ₹23 below the high. Volume reached 2,096,629 shares.

The ₹28 intraday range included movement on both sides of the opening level. The stock's final price was ₹10 below both its opening price and previous close, leaving the November 2 session negative despite trading as high as ₹1,365.

Dr Reddy's remained well above the three reported moving averages. The 50-day DMA was ₹1,230.20, placing the close ₹111.80 higher. The 100-day DMA stood at ₹1,228.30, a difference of ₹113.70. The 200-day DMA was ₹1,237.40, leaving a ₹104.60 gap. The three averages themselves were grouped within a narrow band of less than ₹10.

The share's 52-week range extended from ₹1,101 to ₹1,415. At ₹1,342, the closing price stood ₹241 above the low and just ₹73 below the high. The stock therefore remained considerably closer to its annual peak than to the bottom of the range.

Performance over the displayed periods was positive throughout. One-month return stood at 11.26%, and three months showed 16.89%. Six-month return was a more modest 1.44%, while the one-year figure stood at 12.06%. The strongest of those four periods was the three-month window.

The November 2 decline did not materially change the share's relative position around its broader reference levels. Dr Reddy's remained above all three major DMAs and within ₹73 of its 52-week high despite finishing the day lower.